Low‐dose CLA supplementation, specifically at 100 mg/kg/day, was shown by Miguel Z. Martín‐González to successfully alleviate metabolic disturbances caused by a CAF diet, enhancing obesity‐related metrics and metabolic health without notable side effects (Martín‐González et al. 2020). This evidence concerns the gene SELPLG and obesity due to melanocortin 4 receptor deficiency.